Resultaten visas 1 - 10 / 923
resultat / per sida
Vilka publikationsuppgifter finns i tjänsten?
Publikationens namn
Upphovspersoner
Publikationskanal
År
Publicationer information ikon

Activating somatic mutations outside the SH2-domain of STAT3 in LGL leukemia

Referentgranskad
DOI
10.1038/leu.2015.263
Andersson, E.; Kuusanmaki, H.; Bortoluzzi, S.; Lagström, S.; Parsons, A.; Rajala, H.; van Adrichem, ...
Leukemia2016Publicationer information ikon

Pan-RAF inhibition induces apoptosis in acute myeloid leukemia cells and synergizes with BCL2 inhibition

Referentgranskad
DOI
10.1038/s41375-020-0972-0
Tambe, Mahesh; Karjalainen, Ella; Vähä-Koskela, Markus; Bulanova, Daria; Gjertsen, Bjorn T.; Kontro,...
Leukemia2020Publicationer information ikon

Laying the foundation for genomically-based risk assessment in chronic myeloid leukemia

Referentgranskad
Öppen tillgång
DOI
10.1038/s41375-019-0512-y
Int CML Fdn Genomics Alliance; Branford, Susan; Kim, Dennis Dong Hwan; Apperley, Jane F.; Eide, Chri...
Leukemia2019Publicationer information ikon

Mutational landscape of chronic myeloid leukemia:more than a single oncogene leukemia

Referentgranskad
Öppen tillgång
DOI
10.1080/10428194.2021.1894652
Adnan-Awad, Shady; Kankainen, Matti; Mustjoki, Satu
Leukemia & lymphoma2021Publicationer information ikon

Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia

Referentgranskad
Öppen tillgång
DOI
10.1038/leu.2016.360
Ilander, M.; Olsson-Stromberg, U.; Schlums, H.; Guilhot, J.; Bruck, Oscar; Lahteenmaki, H.; Kasanen,...
Leukemia2017Publicationer information ikon

NK cell dynamics and association with molecular response in early chronic phase chronic myelogenous leukemia (CML-CP) patients treated with nilotinib

DOI
10.1038/leu.2017.235
Sopper, S.; Mustjoki, S.; Gjertsen, B. T.; Giles, F.; Hochhaus, A.; Janssen, J. J. W. M.; Porkka, K...
Leukemia2017Publicationer information ikon

Minimal residual disease of leukemia and the quality of cryopreserved human ovarian tissue in vitro

Referentgranskad
DOI
10.3109/10428194.2015.1065980
Asadi-Azarbaijani, Babak; Sheikhi, Mona; Nurmio, Mirja; Tinkanen, Helena; Juvonen, Vesa; Dunkel, Leo...
Leukemia & lymphoma2016Publicationer information ikon

KIT pathway upregulation predicts dasatinib efficacy in acute myeloid leukemia

Referentgranskad
Öppen tillgång
DOI
10.1038/s41375-020-0978-7
Malani, Disha; Yadav, Bhagwan; Kumar, Ashwini; Potdar, Swapnil; Kontro, Mika; Kankainen, Matti; Java...
Leukemia2020Publicationer information ikon

Germline alterations in a consecutive series of acute myeloid leukemia

Referentgranskad
Öppen tillgång
DOI
10.1038/s41375-018-0049-5
Wartiovaara-Kautto, Ulla; Hirvonen, Elina A. M.; Pitkänen, Esa; Heckman, Caroline; Saarela, Janna; K...
Leukemia2018Publicationer information ikon

Safety and efficacy of the combination of pegylated interferon-alpha 2b and dasatinib in newly diagnosed chronic-phase chronic myeloid leukemia patients

Referentgranskad
DOI
10.1038/leu.2016.121
Hjorth-Hansen, H.; Stentoft, J.; Richter, J.; Koskenvesa, P.; Hoeglund, M.; Dreimane, A.; Porkka, K....
Leukemia2016

Activating somatic mutations outside the SH2-domain of STAT3 in LGL leukemia

Referentgranskad
DOI
10.1038/leu.2015.263
2016

Pan-RAF inhibition induces apoptosis in acute myeloid leukemia cells and synergizes with BCL2 inhibition

Referentgranskad
DOI
10.1038/s41375-020-0972-0
2020

Laying the foundation for genomically-based risk assessment in chronic myeloid leukemia

Referentgranskad
Öppen tillgång
DOI
10.1038/s41375-019-0512-y
2019

Mutational landscape of chronic myeloid leukemia:more than a single oncogene leukemia

Referentgranskad
Öppen tillgång
DOI
10.1080/10428194.2021.1894652
2021

Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia

Referentgranskad
Öppen tillgång
DOI
10.1038/leu.2016.360
2017

NK cell dynamics and association with molecular response in early chronic phase chronic myelogenous leukemia (CML-CP) patients treated with nilotinib

DOI
10.1038/leu.2017.235
2017

Minimal residual disease of leukemia and the quality of cryopreserved human ovarian tissue in vitro

Referentgranskad
DOI
10.3109/10428194.2015.1065980
2016

KIT pathway upregulation predicts dasatinib efficacy in acute myeloid leukemia

Referentgranskad
Öppen tillgång
DOI
10.1038/s41375-020-0978-7
2020

Germline alterations in a consecutive series of acute myeloid leukemia

Referentgranskad
Öppen tillgång
DOI
10.1038/s41375-018-0049-5
2018

Safety and efficacy of the combination of pegylated interferon-alpha 2b and dasatinib in newly diagnosed chronic-phase chronic myeloid leukemia patients

Referentgranskad
DOI
10.1038/leu.2016.121
2016